Moneycontrol PRO
Sansaar
HomeNewsBusinessStocksFortis Healthcare shares hit all-time high; stock gains 1.22% on Nifty Midcap 150

Fortis Healthcare shares hit all-time high; stock gains 1.22% on Nifty Midcap 150

Fortis Healthcare's stock is currently trading near its all-time high, driven by strong financial performance and positive investor sentiment.

August 11, 2025 / 09:46 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Fortis Healthcare hit an all-time high of Rs 908.95 on the NSE in Monday's early trading session. At 9:40 am, the stock was trading at Rs 908.30, a gain of 1.22% and is among the top gainers on the Nifty Midcap 150 index. The stock's new peak reflects strong investor confidence.

    Financial Snapshot

    The company's financial performance shows consistent growth. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,166.72 Crore, up from Rs 1,858.90 Crore in June 2024. Net profit for the same period was Rs 263.86 Crore, compared to Rs 173.39 Crore in the previous year. The Earnings Per Share (EPS) also increased from Rs 2.20 to Rs 3.45.

    Here is a detailed table of the company's quarterly financial performance:

    HeadingJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
    RevenueRs 1,858.90 CroreRs 1,988.39 CroreRs 1,928.26 CroreRs 2,007.20 CroreRs 2,166.72 Crore
    Net ProfitRs 173.39 CroreRs 188.85 CroreRs 252.24 CroreRs 183.38 CroreRs 263.86 Crore
    EPS2.202.343.282.443.45

    The annual consolidated revenue has also shown a strong upward trend. For the year-ending March 2025, the revenue was Rs 7,782.75 Crore, compared to Rs 6,892.92 Crore for the year-ending March 2024. The net profit increased from Rs 635.71 Crore to Rs 797.86 Crore, and EPS rose from Rs 7.93 to Rs 10.26.

    Below is a summary of Fortis Healthcare's annual financial data:

    Heading20212022202320242025
    RevenueRs 4,030.12 CroreRs 5,717.61 CroreRs 6,297.63 CroreRs 6,892.92 CroreRs 7,782.75 Crore
    Net Profit-103.73 CroreRs 765.80 CroreRs 611.15 CroreRs 635.71 CroreRs 797.86 Crore
    EPS-1.457.357.807.9310.26
    BVPS88.9892.83107.30113.33118.11
    ROE-1.798.988.127.818.68
    Debt to Equity0.190.160.100.110.25

    The income statement provides further insights into the company’s financial health. Sales for the year-ending March 2025 reached Rs 7,782 Crore, compared to Rs 6,892 Crore in the previous year. Total income increased to Rs 7,849 Crore from Rs 6,931 Crore. EBIT stood at Rs 1,179 Crore, and after accounting for interest and taxes, the net profit was Rs 797 Crore.

    Key financial ratios for Fortis Healthcare as of March 2025 include a P/E ratio of 68.07 and a P/B ratio of 5.91. The company's debt-to-equity ratio stood at 0.25 for the year-ending March 2025.

    Corporate Actions

    Fortis Healthcare has announced several corporate actions. On August 7, 2025, the company disclosed information regarding analyst/investor meets and newspaper publications. Additionally, there was an announcement on August 6, 2025, concerning a change in management with the re-appointment of a Tax Auditor.

    The company announced a final dividend of Rs 1.00 per share (10%) on May 20, 2025, with an effective date of July 25, 2025. Similar dividends were announced in May 2023 and May 2024.

    Fortis Healthcare's stock is currently trading near its all-time high, driven by strong financial performance and positive investor sentiment.

    Alpha Desk
    first published: Aug 11, 2025 09:45 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347